Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.64 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26818921 | 0.94 | RAB9A (0.58) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL10000939 | 0.94 | RAB9A (0.58) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL24863566 | 0.89 | RAB9A (0.53) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL10000948 | 0.88 | ALDH1A1 (0.51) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL10000943 | 0.88 | MAPT (0.48) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL548066 | 0.87 | TSHR (0.50) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL19351066 | 0.87 | SRD5A2 (0.53) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL22275948 | 0.87 | NPC1 (0.50) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL10000938 | 0.87 | ALDH1A1 (0.50) | RAB9ANPC1ALDH1A1HPGDMAPT | |
| SCHEMBL10975203 | 0.86 | MAPT (0.51) | RAB9ANPC1ALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3996899-B1 | POWDER BED FUSION MATERIAL AND METHOD | SHPP GLOBAL TECH BV (NL) | 2023-08-30 | — | — | EP | disclosed |
| US-11374175-B2 | Polymer, coating composition comprising same, and organic light-emitting device using same | LG CHEM, LTD. | 2022-06-28 | — | — | US | disclosed |
| US-11027242-B2 | Nanofiltration membranes and methods of use | NOVOMER, INC. (US) | 2021-06-08 | — | — | US | disclosed |
| US-10844179-B2 | Bridged silicone resin, film, electronic device and related methods | DOW SILICONES CORPORATION (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200172678-A1 | BRIDGED SILICONE RESIN, FILM, ELECTRONIC DEVICE AND RELATED METHODS | DOW SILICONES CORPORATION | 2020-06-04 | — | — | US | disclosed |
| US-20190255488-A1 | NANOFILTRATION MEMBRANES AND METHODS OF USE | NOVOMER, INC. (US) | 2019-08-22 | — | — | US | disclosed |
| US-20190185624-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2019-06-20 | — | — | US | disclosed |
| US-10312502-B2 | Lithium electrode and lithium secondary battery comprising same | LG CHEM, LTD. (KR) | 2019-06-04 | — | — | US | disclosed |
| US-10245559-B2 | Nanofiltration membranes and methods of use | NOVOMER, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-9876211-B2 | Separation membrane and lithium-sulfur battery comprising same | LG CHEM, LTD. (KR) | 2018-01-23 | — | — | US | disclosed |
| US-20170226054-A1 | FLUORINE-BASED COMPOUND FOR BRANCHER, POLYMER USING SAME, AND POLYMER ELECTROLYTE MEMBRANE USING SAME | LG CHEM, LTD. (KR) | 2017-08-10 | — | — | US | disclosed |
| US-20170104209-A1 | LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-04-13 | — | — | US | disclosed |
| US-8859715-B2 | Polyimide polymer solution, polyimide polymer, transparent film, displaying device and solar cell | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-10-14 | — | — | US | disclosed |
| US-20120160317-A1 | POLYIMIDE POLYMER SOLUTION, POLYIMIDE POLYMER, TRANSPARENT FILM, DISPLAYING DEVICE AND SOLAR CELL | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-06-28 | — | — | US | disclosed |
| EP-1255738-B1 | GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO | NEUROCRINE BIOSCIENCES INC (US) | 2012-03-07 | — | — | EP | disclosed |
| US-7462625-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-7462625-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-20070208049-A1 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-09-06 | — | — | US | disclosed |
| US-20070208049-A1 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-09-06 | — | — | US | disclosed |
| US-7179815-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10245559-B2 | Nanofiltration membranes and methods of use | MLEC, EPCAM, LNPK | RAB9A 1123/4885NPC1 698/4885ALDH1A1 1130/4885 |
| US-20190255488-A1 | NANOFILTRATION MEMBRANES AND METHODS OF USE | MLEC, EPCAM, LNPK | RAB9A 1123/4885NPC1 698/4885ALDH1A1 1130/4885 |
| US-11027242-B2 | Nanofiltration membranes and methods of use | MLEC, EPCAM, LNPK | RAB9A 1123/4885NPC1 698/4885ALDH1A1 1130/4885 |
| US-20170226054-A1 | FLUORINE-BASED COMPOUND FOR BRANCHER, POLYMER USING SAME, AND POLYMER ELECTROLYTE MEMBRANE USING SAME | AFF4, AFF2, PFAS | RAB9A 2524/4885NPC1 1852/4885ALDH1A1 985/4885 |
| US-20070208049-A1 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | GNRHR, GHRHR, LHCGR | RAB9A 1093/4885NPC1 1959/4885ALDH1A1 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.